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Abstract
Many published data have demonstrated the potential of radon exposure to induce 
biological damage. All these studies suggest that exposure to radon and its prog-
eny can represent a significant public health risk. Radon exposure is considered as 
the second cause of lung cancer and it is the first in never smokers. Many countries 
have depicted residential radon exposure maps in order to characterize those areas 
with the highest indoor radon concentrations. There are areas in Kazakhstan with a 
number of factors leading to natural radioactivity. The genotoxic effects of radon on 
population of Kazakhstan are poorly understood. These studies conducted in compli-
ance with all requirements of genotoxic studies will provide an extensive and reliable 
data for a detailed radon zoning of Kazakhstan. Our review attempts to integrate data 
about the association between residential radon levels and morbidity of population in 
Kazakhstan. In addition, we tried to cover all points of the cytogenetic and molecular 
changes induced by radon exposure.
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1. Introduction
The radioactive contamination is a significant factor affecting the environment and human 
health. Radon and its decay products are the major contributors to human exposure from 
natural radiation sources. WHO has identified the chronic residential exposure to radon and 
its decay products as the second cause of lung cancer after tobacco consumption and the 
most common cause of lung cancer in non-smokers. Radon is a chemically inert radioactive 
gas, occurring naturally as an indirect decay product of uranium. Uranium has been actively 
mined and milled in the Republic of Kazakhstan [1]. Uranium ore mining and processing 
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were initiated in Kazakhstan shortly after Second World War, and lasted for almost half a 
century. It has been estimated that during the Soviet period, about 30–40% of the uranium 
was extracted from the Asian region [2, 3].
Accordingly, the population of Kazakhstan might be exposed to a variety of hazardous mate-
rials including radon. Almost the whole eastern and northern part of Kazakhstan is potentially 
radon-affected area. The analysis of the cancer rate on the territory of Kazakhstan showed that 
there is a significant relationship between the areas with high level of morbidity and radon-
affected areas. It is worth emphasizing that lung cancer is ahead of other cancer diseases in 
some areas of Kazakhstan that are radon-affected territories.
Lung cancer in the structure of oncology occupies the second rank position, and its 
share at the moment was 11.4%. This is the most widely distributed form of cancer 
leading since 1985 in Republic. The highest morbidity of lung cancer is observed in the 
North Kazakhstan, Pavlodar, Akmola, and East Kazakhstan regions. Almost the whole 
of Kazakhstan to the east of the Kustanai-Shymkent line (North Kazakhstan, Pavlodar, 
Akmola, East Kazakhstan, Kustanai and Karaganda regions) is potentially radon-affected 
areas. Thus, it becomes evident that one of the measures to reduce the incidence of lung 
cancer is to identify areas with high level of radon and reduce the impact of radon on the 
population.
When radon is inhaled, α-particles could affect lung tissue and may cause lung cancer via 
DNA and oxidative damages [4]. However the molecular effect of radon on lung cancer is not 
understood.
In addition to the mutations that arise in oncogenes or tumor-suppressor genes that are 
necessary for tumor transformation, epigenetic changes can play a key role in the patho-
genesis of cancer. At the epigenetic level, specific alterations including alterations in DNA 
methylation, histone modifications leading to generation of γ-H2AX species (indicative of 
double-strand DNA breaks) and miRNAs expression patterns have been associated with 
radon exposure. Nevertheless, the mechanistic details underlying the molecular path-
ways by which genetic and epigenetic mechanisms are associated with lung cancer remain 
unclear. This review attempts to integrate data about the association between residential 
radon levels and morbidity of population in Kazakhstan living in these regions. In addi-
tion, we tried to cover all the points of the cytogenetic and molecular changes induced by 
radon exposure.
2. Uranium pollution in Kazakhstan
Uranium (U) is a radioactive chemical element of group III of the periodic system with atomic 
number 92 that belongs to the family of actinides. Uranium is readily soluble in water, easily 
reacts with the basic elements of organic compounds. In nature, uranium is found as ura-
nium-238, uranium-235, and a very small amount of uranium-234.
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The Republic of Kazakhstan is rich for uranium deposits and second in the world for min-
ing resource, which contributes to the pollution of the environment with uranium tailings. 
Total deposits are estimated to be 2 million tons, representing 25% of uranium deposits in 
the world. The mining and milling of uranium ore have caused contamination of the environ-
ment through a number of activities, especially the open-pit mining process, transportation 
to and from milling sites, the milling and processing of ore, and open-air storage of radioac-
tive and non-radioactive mining wastes. The main concern in Kazakhstan is that approxi-
mately 85% of the urban population lives in territories where environmental pollution is 
known to exceeded permissible standards [5, 6] together with vastly unknown contamina-
tion problems.
The largest region enriched with the uranium deposits is located within the North Kazakhstan 
containing approximately 16.4% of the uranium resources of Republic [7]. Besides, there are 
also large storage facilities for the radioactive waste in the North and West Kazakhstan. The 
total area exposed to radioactive waste from the uranium industry enterprises is estimated to 
approximately 100,000 hectares with a total activity of 250,000 Curie. In mining, the uranium 
and its decay products buried deep in the earth are brought to the surface, and the rock con-
taining them is crushed into fine sand. After the uranium is chemically removed, the sand is 
stored in huge reservoirs [8]. Conservation and liquidation of uranium deposits in northern 
Kazakhstan was completed in 2008 in accordance with the State program “Preservation of 
non-uranium mining enterprises and liquidation of the consequences of uranium deposits 
for 2001–2010” [9].
The decay chain of uranium is commonly called the “uranium series” or “radium series” and 
includes protactinium, radium, thorium, and radon.
The high levels of radon are observed in the North and East areas of Kazakhstan because of 
the natural radiation sources and the long-term and large-scale mining of uranium.
3. Characteristic of radon and its decay product
Radon (Rn) is a radioactive colorless and odorless inert gas. In nature, radon occurs in two 
forms: radon-222 (222Rn), formed by the decay products of uranium-238; and radon-220 is the 
product of the decay of thorium-232. However, most of the radioactivity in the atmosphere at 
sea level is attributable to 222Rn. For that reason, the term “radon” identifies mainly the 222Rn.
The main sources of indoor radon are soil, building materials, water sources, natural gas, and 
outdoor air. There is a large variation of indoor air concentrations of this gas, mainly depend-
ing on the geology of the area and on factors affecting the differential pressure between inside 
and outside of the buildings, such as ventilation rates, heating systems, and meteorological 
conditions. The rocks with high radioactivity and tectonic faults with the high emanation 
can lead to a significant increase of radon concentration indoor and its contribution becomes 
dominant in the collective dose of the population.
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4. Indoor radon data in Kazakhstan
According to the experts, the contribution of natural sources in the average annual radia-
tion dose of the Kazakhstan population currently stands at 80%, including 50% from radon. 
The level of average annual radiation dose due to radon for the population of Kazakhstan is 
 considered to be 1.5 times higher than the world average [10].
As showed in Summary Report “Legacy of uranium mining activities in central Asia— 
contamination, impact and risks”, the highest dose contribution to humans was derived from 
indoor radon concentrations in houses and dwellings in the vicinity of the Kurday site. The 
values of indoor and outdoor radon concentrations in Kurday are considerably higher than 
global average corresponding values. The indoor radon concentrations (70–330 Bq/m3) were 
found to be higher than the outdoor radon concentrations (30–90 Bq/m3) [11].
In some settlements in 70% of the buildings, radon concentration exceeds the maximum per-
missible concentration (200 Bq/m3). There are official data showing that the concentration of 
radon in the soil in some areas of Kazakhstan reaches 300,000 Bq/m3, and the concentration of 
indoor reaches 6000–12,000 Bq/m3, which exceeds the maximum permissible concentration by 
60 times [12]. The radon-affected areas in Kazakhstan are shown in Figure 1.
Stegnar et al. [2] measured indoor 222Rn concentrations in 27 selected houses and public build-
ings in Ust-Kamenogorsk city in East Kazakhstan area. According to their data, the values 
of radon ranged from 22 to 2100 Bq/m3, the average concentration of radon was 230 Bq/m3. 
The corresponding annual effective doses ranged from 0.5 to 20 mSv, the average dose being 
Figure 1. Radon-affected areas of Kazakhstan.
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5 mSv per year. The studies conducted in Altai (East Kazakhstan) revealed radon levels from 
200 to 8000 Bq/m3 in 15 of the 18 settlements [13].
The territory of North Kazakhstan is characterized by the areas with the high levels of radia-
tion, arising both from natural radiation sources, as well as by long-term and the large-scale 
activities of uranium mines and uranium-processing companies [11].
The Akmola region (North Kazakhstan) is one of the largest world’s uranium ore provinces. It 
contains more than 30 uranium deposits [12]. During 50 years, open and underground mining 
of uranium ore was conducted in the North Kazakhstan that led to the accumulation of the 
significant amount of radioactive waste with the high risk of radioactive contamination to the 
environment and toxic effects on the human health. All these factors contribute to the forma-
tion of elevated concentrations of radon in this region. The measurement of the radon activity 
in indoor air was carried out in 2010 in the territory of three districts of Akmola region. As a 
result of this work, 47 settlements regions were revealed, including the Astana and Kokshetau 
cities, 35 settlements (76.1%) which were characterized by excess of standard values (200 Bq/m3) 
radon activity [12].
In 2010, 814 measurements of radon in indoor air of the residential and public buildings were 
carried out in Astana in order to implement the preventive health surveillance. Exceeding 
levels of radon has been established in eight newly built homes (207–1150 Bq/m3). It also 
revealed that excess radon activity in the Balkashino village school (1022 Bq/m3) and in the 
preschool of the village “Shantobe” (789 Bq/m3). It revealed maximum values of 222Rn activity 
in the settlements: Vasilkivka—866 Bq/m3, Granite—611 Bq/m3, and Ondiris—419 Bq/m3. In 
the village of Aksu, there were 42 surveyed areas of which 22 cases were detected exceeding 
the permissible radon activity. Activity of radon in homes ranged from 8 to 858 Bq/m3, in 
schools—153–2162 Bq/m3, and in the basement—130–5870 Bq/m3. In Saumalkol village, the 
value of radon activity was in the range from 590 to 3977 Bq/m3. In some kinder gardens of 
Aryk-Balyk village, radon concentrations range from 510 to 4500 Bq/m3, that is in 22.5 higher 
than the allowable level of 200 Bq/m3. The most famous case of a high level of radon in mines 
and in a residential area in Kazakhstan is mine “Akchatau”. The major sources of 222Rn con-
centration, in the opinion of Soroka and Molchanov, in dwellings in Akchatau village was 
condition radon flux from the surface of the granite massive (especially in a zone of geologi-
cal rupture) and radioactivity of local construction materials (granite and adobe) including 
sand from mill plant tailings. The high level was of radon in 44% of the residential buildings 
in Akchatau village with a peak concentration at 37,650 Bq/m3 [14]. It was under a compre-
hensive survey of radon in mines and homes, as well as the health of miners and residents. 
As a result, it has been found that the incidences of respiratory diseases, nervous system, and 
cardiovascular system exceed the average for the region is 2.9 times. It is most likely indicative 
of radon exposure on the health of the village.
A large group of the population is exposed to radon in the workplace. It is interesting that 
the workers employed in the mining and processing of non-ferrous metals most affected by 
radon, but not the workers of uranium mines. This is due to the fact that, there are high 
 concentrations of naturally radioactive dust in the air. In some cases, exposure doses for lungs 
of underground miners exceeded 5 Sv y−1, while the allowable level is 0.015 Sv y−1 [15].
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In Almaty city, during the period from 1990 to 1993, preliminary measurements of level of 
radon in public buildings and kindergartens were carried out. Several places with level of 
radon between 380 and 532 Bq/m3 were identified [16]. In some other areas of the North 
Kazakhstan region (Akkol, Yenbekshilder, and Sandyktau villages), 112 settlements were 
examined. More than 60% of the settlements were identified with exceeding activity of radon 
in indoor air and the drinking water sources in 32% of villages.
5. Radon concentrations in drinking water in Kazakhstan
The source of drinking water in most parts of Kazakhstan is groundwater and in many settle-
ments there are no alternative sources of drinking water. However, often underground water 
is saturated with uranium, radium, radon, the concentrations of which exceed the permissible 
level. Therefore, a survey of water sources and water quality control are extremely relevant 
for preventing radiation risk of the population.
The active study of the concentrations of the natural radioactive elements in natural waters 
in Kazakhstan began in the late 1940s of last century due to an increase in geological pros-
pecting for radioactive materials. From 1960 to 1992, the entire territory of Kazakhstan was 
covered by the hydrogeological surveys for water supply of the settlements. To carry out 
these activities in large volumes, the strictly regulated selections of water samples were 
conducted for determination of uranium, radium, and radon. The amount of available 
information in the archives and reports of specialized organizations includes information 
on approximately 30,000 water sources [5]. It has been shown that in the drinking water of 
some settlements, specific activity for 238U reached 96 Bq/l, activity for 226Ra 45 Bq/kg, and 
activity for 222Rn 5100 Bq/kg [17].
In Kazakhstan, there are numerous sources of radon waters, which are determined by the 
presence of highly radioactive rocks enriched in uranium. Basically, water sources with a high 
content of radon (more than 100 Bq/l) are located in the submontane and mountain regions 
in the south, south-east, and north of Kazakhstan. These are uranium provinces Kendyktas-
Chuili-Betbakdalin (Zhambyl, Almaty regions), North Kazakhstan (Akmola region) and the 
North-Pribalkhash rare-metal area (Karaganda region). In these regions, especially in villages 
near the mines, radiological services have identified the most numerous cases of high radon 
level in the air of residential and industrial premises.
The radiological evaluations of drinking water were carried out according the norms estab-
lished by “Sanitary requirements for radiation safety” representing the main technical docu-
ment regulating norms of ionizing radiation in Kazakhstan. According to this document, the 
contents of the natural and artificial radionuclides in drinking water, creating an effective dose 
less than 0.1 mSv/year does not require measurements to reduce the radioactivity of  drinking 
water. Over the last years in Akmola region (North Kazakhstan), 1271 drinking water sam-
ples were investigated, from which 550 samples did not meet the standards for total alpha 
activity (43%). On average, the radiation dose of the population received drinking water is 
0.21 mSv/year in this region [12]. Thus, studies on groundwater sources in North Kazakhstan 
Radon98
have shown the presence of radon in drinking water sources from 8 to 300 Bq/l. A total of 32 
surveyed drinking sources in 15 cases (47%) had high levels of radon in drinking water [12].
The studies of groundwater in Ust-Kamenogorsk (East Kazakhstan), conducted in 2005, 
showed the average level of radon (222Rn) 60 Bq/l [12]. The concentration of radon in drink-
ing groundwater may be associated with the presence of water in its long-lived daughter 
product 210Pb, which is one of the most radiotoxic beta-active natural radionuclides.
6. Health effect of uranium on the population in Kazakhstan
The analysis of medical statistics of North Kazakhstan showed that the level of overall mortality 
and cancer among adults and children is one of the highest in the region [18], although it has 
not revealed a direct relationship between these indicators and the radiation factor as a result of 
uranium mining and processing enterprises.
The production of uranium involves a large contingent of workers whose work takes place 
in the specific conditions exposing to radiation and chemical factors present in the ore 
mined. Klodzinskiy et al. [19] have shown a deterioration of health of uranium miners in 
North Kazakhstan. The results of epidemiological and medical studies found the high fre-
quency of respiratory diseases (61%) in the cohort of uranium miners in North Kazakhstan. 
According to Ref. [20], the most common somatic diseases among uranium workers of 
Stepnogorsk city were hypertension, chronic obstructive pulmonary disease, and chronic 
gastritis. Moreover dysfunction of all parts of the immune system was observed in the stud-
ied groups of uranium workers [21]. Comprehensive clinical assessment of health  status 
of children and adults living near Stepnogorsk uranium-processing enterprises showed a 
high risk of developing chronic diseases in internal organs due to long-term toxic effects 
of radiation. The study of reproductive health of women living in areas adjacent to the 
uranium mines showed a low percentage of healthy women (13%) [22]. Among children 
in Stepnogorsk city, the urinary tract infections and chronic bronchitis amounted to a high 
percentage of the total somatic pathology [23].
In our previous study [24, 25], uranium mine workers in the Stepnogorsk mining-milling 
complex in North Kazakhstan were investigated for the expression of chromosome aberra-
tions and for genetic factors that can modify the exposure-related expression of chromosome 
damage. The study has demonstrated an increased frequency of chromosomal aberrations in 
uranium miners compared to the matched control subjects, which were not exposed to ura-
nium compounds or to any other known chemical or physical mutagens. The study of chro-
mosomal aberrations in the workers of uranium mining showed a high frequency of acentric 
chromosomes, dicentric and centric ring chromosomes in dose/ dependent manner.
The uranium workers were classified into three groups according to their duration of expo-
sure: group I: 1–10 years, II: 11–20 years, and III: 21–25 years. The received data show that all 
three groups of workers had higher frequencies of chromosomal aberrations than the control 
group. In the first group of workers, the frequency of dicentrics was higher (1.95 ± 0.15) than 
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that of the matched control group (0.50 ± 0.09) (0.05 < p < 0.01). In the second group of uranium 
workers, the frequency of dicentrics and the total chromosomal aberrations were significantly 
higher (2.33 ± 0.17) than the control group (0.55 ± 0.08). In the third group of workers, the fre-
quency of chromosomal aberrations was also significantly higher (2.68 ± 0.26) than the control 
group (0.36 ± 0.10). The frequency of chromosomal aberrations observed in exposed group III 
was also higher compared to the first and second exposed groups (0.05 < p < 0.01).
Furthermore, a significant increase in the frequency of chromosomal aberrations in the work-
ers who were heavy smokers was observed compared with those who were moderate smok-
ers or non-smokers. Uranium-exposed workers who had inherited the null GSTM1 and/or 
GSTT1 genotypes had a significant increase in the frequency of chromosome aberrations com-
pared with those who had intact GSTM1 and GSTT1 genes for different group of workers 
[26]. We have shown that the uranium mining conditions in North Kazakhstan can cause a 
long-term health risk among the workers. In uranium miners, the various forms of malignant 
tumors of the lung, liver, and stomach were observed [27].
Lung cancer is the leading cause of cancer death and the second most common cancer among 
population in the Kazakhstan (11.4%). The incidence of lung cancer in men is higher than in 
women and accounts for 20% of the total number of cancer diseases. Over past 30 years in East 
Kazakhstan, there was a sharp increase in cancer rates. This growth is particularly noticeable 
in the Ust-Kamenogorsk city. The increase in total cancer morbidity indicator is mainly due to 
an increase in the incidence of lung cancer, breast cancer, and skin cancer [28].
As mentioned above, the villages where there is a high radon activity, marked by the territory 
of Kazakhstan, are characterized by the highest levels of radon in East and North Kazakhstan 
(67% of settlements in excess). Interestingly, in the Eastern and Northern part of the coun-
try, there is an increase (up to 1.5 times or more) in cancer rates, which makes it possible to 
assume a correlation between radon levels and cancer incidence [29].
Influence of environmental factors including radon on cancer development among population 
of North and East Kazakhstan regions were investigated by group of researchers from North 
Kazakhstan State University. They found a positive association between residential radon con-
centration in these two regions of Kazakhstan and different cancer diseases, predominating 
lung cancer [29].
7. Health effect of radon
Alpha radiation in chronic exposure can cumulate the biological effect. In comparison with 
the damaging effects of beta and gamma radiation, alpha particles cause 23–43 times more 
severe radiation damage. The long-term after effect of the radon is its high blastomogenic 
activity.
The role of radon and its radioactive decay products as human carcinogens has been estab-
lished by the International Agency for Research on Cancer in 1988 and is supported by 
experimental evidences obtained in laboratory animals [30] and epidemiologic studies in 
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humans [31]. In 1990, Schoenberg et al. [32] published a report on the strong association 
between indoor radon exposure and lung cancer risk. In 2002, Wang et al. [33] has shown 
that high levels of residential radon increase the risk of lung cancer. Some studies dem-
onstrated that lung cancer risk increases with increasing indoor radon concentration. As 
reported by Darby et al. [34], cumulative risk of lung cancer when reaching the age of 
75 years is estimated to never smokers at 0.4, 0.5, and 0.7% for the radon concentrations of 0, 
100, and 400 Bq/m3, respectively. While cumulative risk of lung cancer at the age of 75 years 
for smokers reaching 10, 12, and 16% for radon concentrations of 0, 100, and 400 Bq/m3, 
respectively. Baysson et al. [35] found that the risk of lung cancer increases from 4 to 28% 
with increasing radon levels per 100 Bq/m3. Moreover, the risk of cancer increases in smok-
ers group from 2 to 80% with an increasing radon levels per 100 Bq/m3.
Specifically, radon emerged as a prominent non-tobacco carcinogen strongly associated with 
lung cancer. Although the initial evidence supporting the association of radon and lung  cancer 
came from studies involving mine workers, in recent years research has focused on indoor 
Radon exposure and its risk to the general population. In 2009, the WHO identified chronic 
residential exposure to radon and its decay products as the second cause of lung cancer after 
tobacco consumption and as the main risk-factor in never smokers [36]. Torres-Durán et al. 
[37] studied 192 lung cancer cases and 329 controls in Galicia, Spain. The study subjects were 
male or female never smokers aged over 30 years. According to their study, adenocarcinoma 
was the most common histologic type of lung cancer.
In the literature, there are different data on the histological types of lung cancer induced by 
radon. Some studies have reported that radon increases the risk of small cell lung cancer. 
Barros-Dios and colleagues [38] found that less frequent histologic types (including large cell 
carcinomas), followed by small cell lung cancer, had the highest risk associated with radon 
exposure. According to the study of Taeger et al. [39], a small cell lung cancer and squamous 
carcinoma is associated with the radon exposure, but adenocarcinoma is associated less. Some 
studies have found a positive correlation between the incidence of adenocarcinoma in the 
group of non-smoking women and the increasing concentration of radon in the living room 
[40]. Wilcox et al. [41] failed to show a statistically showed that radon exposure had a strong 
effect on small cell lung cancer in cases of both genders, but the causative relation of indoor 
radon and squamous cell carcinoma was only demonstrated in male cases. Some studies have 
showed evidence that indoor radon exposure is strongly related to small cell carcinoma and 
squamous cell carcinoma of the lung.
It is considered worldwide that 3–20% of all lung cancer deaths are caused by indoor radon 
exposure [42]. The highest estimate of percent risk of lung cancer deaths, which consist 20% from 
whole mortality of lung cancer, was reported in the study for an average radon concentration 
of 110 Bq/m3 [43]. The lowest indoor radon concentration (21 Bq/m3) was measured in the UK, 
which also showed the lowest percent risk (3.3%) of lung cancer deaths [44].
The recent studies in Spain have shown a statistical association between indoor radon and 
lung, stomach, and brain cancer in women [45]. Thus, the effect of radon is not limited to an 
increased risk of lung cancer, but it can also lead to the development of pathological changes 
in other organs. The results of mortality studies in North Carolina showed that groundwater 
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radon is associated with increased risk not only for lung but also for stomach cancer [46]. 
Barbosa-Lorenzo et al. also observed a strong and significant association between residential 
radon and the incidence of stomach cancer, but their findings were limited by a low number 
of cases [47]. There are very few studies on other cancers different than lung and stomach 
cancer.
Bräuner et al. [48] found significant associations between long-term exposure of radon to 
Danish population and risk of primary brain tumors. Exposure of ionizing radiations has 
been shown to increase the risk of central nervous system tumors in children and adolescents 
exposed to computed tomography scans [49]. Some epidemiological studies have suggested a 
positive correlation between environmental radon exposure and prostate cancer [50]. A study 
in Galicia (Spain) showed a correlation between brain cancer mortality and indoor radon 
exposure [51].
Li and colleagues’ study demonstrated the evidence of malignant transformation of human 
benign prostatic epithelial cells exposed to a single dose of alpha radiation [52]. The results of 
study for breast cancer in Spain shown a certain association between breast cancer risk and 
radon exposure might be present [45]. However, Turner et al. did not find any association for 
radon exposure and breast cancer mortality [53].
Recent study observed a significant positive association between mean county-level residen-
tial radon concentrations and chronic obstructive pulmonary disease mortality [54].
The risk for bronchopulmonary system following inhalation of radon is significantly 
higher than for other organs. A detailed study of lung cancer showed that due to the 
peculiarities of the movement of the mucus and the depth of the location of the basal cells, 
there are some “risk cells” that receive the highest dose of alpha radiation on exposure 
to radon.
From the molecular viewpoint, the mechanism of lung cancer induction by radon is not 
known in detail, but involves both genetic and epigenetic pathways [55, 56].
Because radon is inert, nearly all of the gas that is inhaled is subsequently exhaled. However, 
222Rn decays into a series of solid short-lived radioisotopes depositing within the respira-
tory tract. Because of its relatively short half-lives, the radon-progeny mainly decay in the 
lung before clearance can take place. Two of these short-lived progeny, Polonium-218 and 
Polonium-214, emit radioactive alpha particles that, impacting pulmonary epithelium, may 
genetic-molecular alterations that are mutagenic and result in an increased risk of carcino-
genesis [57].
8. Health effect of radon on the population of Kazakhstan
Epidemiological studies show that age-standardized cancer rate in former NIS countries 
(New Independent States), including Kazakhstan, doubled during the last 20 years. Release 
of radioactive and toxic debris into the environment could contribute to such an increase. 
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During the last decades, contamination by industrial or military wastes in Kazakhstan may 
have contributed to the observed health problems. One of the most heavily polluted areas 
in Kazakhstan, where environmental pollution exceeds permissible standards, is the East 
Kazakhstan province. In this area mining and smelting industries and metallurgic complexes 
are extensive. About half of solid toxic waste (49.2%) accumulated in Kazakhstan are located 
around enterprises. Surveys of environment exposure to genotoxic agents, including uranium 
and its short-lived radioactive alpha- and beta-emitting particles, show that environmental 
health problems in this region are critical, due to the industrial activity of different metallur-
gic complexes and accumulation of high concentrations of hazardous toxicants.
For the first time in Kazachstan, complex studies on the effect of radon on the incidence disease 
were conducted in the Zhezkazgan region [58]. In 1985, the high level of radon in the village of 
Akshatau was detected. The morbidity of 2166 inhabitants of all social and age groups of this 
settlement was studied. From 1986 to 1990 average morbidity was 19,927 cases per 10,000 of the 
population, which was 2.9 times higher than in Zhezkazgan region.
The highest percentage of all diseases was accruing to respiratory diseases (62.2%). The  second 
place was occupied by diseases of the nervous system and sense organs (9.3%), the third 
place—diseases of the circulatory system (7.1%). Analysis of the morbidity structure showed 
that people living in houses with a high indoor radon level often sought medical advice, espe-
cially with symptoms of bronchopulmonary diseases. These cases of seeking medical advice 
accounted for 63.1% of all diseases and 66.2% of bronchopulmonary diseases. The highest 
morbidity was observed among children who lived in houses and visited kindergartens func-
tioning in buildings with high indoor radon level (48,625 cases per 10,000 of the population 
of this age), which 4.6 times higher comparing with children who living in homes with low 
radon levels. A significant difference in the incidence of respiratory organs was observed 
in newborns living in houses built using waste from uranium production. The morbidity 
reached 40,866 cases per 10,000 populations, accounting for 81.1% of the total respiratory 
morbidity in children of this age. About 65.6% of seeking medical advice among children of 
school age due to respiratory diseases occurred in those living in houses with a high level of 
radon and attending school, in which the level of natural gamma background exceeded the 
permissible level 7.7 times. The most common forms of respiratory diseases in the children, 
described above, were acute bronchitis, pneumonia and acute infections of the upper respi-
ratory tract. In the adult population of the Akshatau village the highest morbidity level was 
among people working with the extraction and processing of uranium-bearing ore. Among 
morbidity of adults were most common chronic and acute bronchitis, chronic diseases of ton-
sils and adenoids, chronic pharyngitis and nasopharyngitis, acute laryngitis and tracheitis, 
pneumonia and emphysema [58].
Scientific-research Institute for Radiation Medicine and Ecology of Semey in 2013–2014 con-
ducted a study of radon symptoms in the Kalachi village of Akmola region because of the 
increase of cases of so-called “Kalachi syndrome” among residents of the village. Of the 59 
investigated buildings (residential and social significance) 20% of the buildings’ mean values 
of radon volume activity do not meet the requirements of existing regulations. There is a rela-
tionship of “Kalachi syndrome” with points of high radon concentrations. In addition to the 
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risk of developing lung cancer should be noted the property of radon as inert gas to exhibit 
an anesthetic effect [59].
In accordance with the Decree of the Government of the Republic of Kazakhstan No. 34 of 
13-01-2004, “On the approval of the list of diseases associated with exposure to ionizing radi-
ation and the Rules for Determining the Causation of Diseases from Exposure to Ionizing 
Radiation” the following list of diseases associated with exposure to ionizing radiation was 
approved:
1. Acute leukemia (leukemia)
2. Malignant lymphomas





8. Gastric cancer (including oral, pharynx, esophagus, stomach and colon cancer).
The analysis showed that the population of Kazakhstan lives primarily in potentially danger-
ous areas from the radioactivity exposure point of view. According to studies, level of radon 
in premises where people stay for long times may exceed allowable levels by several times. 
Accordingly, the study of the risks of radon-induced diseases, and primarily lung cancer, is 
necessary.
9. Lung cancer in Kazakhstan
The incidence rates of malignant diseases in various areas vary quite widely (Table 1). It 
can be noted that the average number of diseases per 100,000 population in regions with an 
increased level of radon hazard (North Kazakhstan, Pavlodar, East Kazakhstan, Kostanay, 
Karaganda, Akmola, and Almaty) is 276, while the average number of diseases per 100,000 
population by regions with a normal level of radon hazard (Aktobe, Atyrau, Zhambyl, West 
Kazakhstan, Kyzylorda, Mangystau, and South Kazakhstan)—145.5.
The data on cancer incidence by regions are given in Table 1 and in Figure 2. A compara-
tive analysis of this map and a map of radon-affected areas (Figure 1) indicates a correlation 
between the incidence of cancer and the level of radon hazard.
Of course, for this analysis, more detailed studies are needed. For example, the areas of South 
Kazakhstan, Almaty, and parts of Kyzylorda regions are classified as potentially radon-affected 
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areas because they are located in the territories of uranium provinces. However, these areas 
are characterized by low cancer rate. This is explained by the fact that unlike typical uranium 
provinces (e.g. the North Kazakhstan province), uranium deposits in these areas are located at 
great depths and do not surface.
However, when comparing the levels of radon and the cancer rate, there is a sufficient cor-
relation, indicating an undoubted dependence of oncological morbidity and radon hazard. 
This dependence is complex and requires a more detailed study, on the one hand, of various 
factors affecting the health of the population: chemical pollution, smoking, etc., and on the 
other hand— natural geological features of the territory.
It is possible to distinguish two groups of sources of radon intake from the subsoil. Firstly, 
the sources are the rocks themselves with a high geochemical background, which can have a 
radon concentration in the ground up to 50–100 Bq/l, which can form radon-affected areas. 
Secondly, the source is radon-bearing tectonic zones with well-defined linear parameters. The 
level of radon in the air of houses located in such zones can reach very high values, reaching 
10 thousands of Bq/m3.
The frequency of lung cancer by region almost completely coincides with the incidence of 
cancer.
Region 2012 2013 Rate of increase (%)
Republic Kazakhstan 190.6 193.9 1.7
Akmola 233.6 248.5 6.4
Aktobe 173.9 179.1 3.0
Atyrau 124.4 140.5 13.0
East Kazakhstan 276.2 285.5 3.4
Zhambyl 129.5 139.9 8.1
West Kazakhstan 207.5 207.3 –
Karaganda 257.1 258 0.4
Kyzylorda 139.6 138 –
Kostanay 291.9 278 –
Mangystau 113.9 123.6 8.6
Pavlodar 301.5 301.9 0.1
North Kazakhstan 309.2 312.5 1.1
South Kazakhstan 93.3 98.6 5.7
Astana 169.2 172.3 l.8
Almaty 245.2 247.9 1.1
Table 1. Cancer morbidity in Kazakhstan (per 100,000 people).
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In the structure of the incidence of cancer lung ranks first place in Akmola, Aktyubinsk, 
Atyrau, Kostanay, Pavlodar, and North Kazakhstan regions, the second place in East 
Kazakhstan, Zhambyl, West Kazakhstan, Mangystau regions, and Astana city, the third place 
in Karaganda, South Kazakhstan, and Almaty.
Lung cancer in the structure of oncology occupies the second rank position, and its share 
at the moment was 11.4%. This is the most widely distributed form of cancer which lead-
ing since 1985 in Republic. The highest morbidity of lung cancer is observed in the North 
Kazakhstan, Pavlodar, and Akmola regions.
When analyzing the morbidity of lung cancer in the East Kazakhstan region, the areas with 
a higher lung cancer rate (more than 40/100,000 of population) are clearly associated with a 
radon-affected territory in the northern part of the region. In 15 settlements of 18 examined in 
this area, the excess of the norm (sometimes significant—up to 40 times) of radon concentra-
tion was established.
The area with increased oncological morbidity in the northeast of the East Kazakhstan region 
borders on the territory with an increased incidence in the Altai territory (Russia) [58].
However, the genotoxic effects of radon on population of Kazakhstan are poorly understood, 
in spite of the fact that many regions of the country contain the high levels of radon. Studies 
elucidating potential health risk among population exposed to radon and genotoxic effect of 
radon in Kazakhstan are very limited or these studies have never conducted in some areas.
10. Genetics and epigenetic effects of radon
Alpha particles interact with DNA either directly or indirectly through the generation of 
free radicals, leading to double-strand breaks, large chromosomal aberrations, and point 
Figure 2. Cancer rate in the Republic of Kazakhstan.
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mutations. In a previous cytogenetic study conducted on a population residing near ura-
nium tailings and mining activities in North Kazakhstan, we have demonstrated an increased 
frequency of chromosomal aberrations in uranium miners compared to matched control 
subjects, who were not exposed to uranium compounds or to any other known chemical or 
physical mutagens. The data on aberration type frequency showed a predominance of aberra-
tions of chromosome type in the exposed group, mainly including paired acentric fragments, 
dicentric chromosomes, and centric rings [60].
Several investigations on chromosome aberrations of blood lymphocytes due to radon expo-
sure were previously carried out. In a study by Hellman et al. with human blood samples 
to detect DNA damage, an increased concentration of radon in indoor air was found to be 
associated with enhanced DNA damage in peripheral lymphocytes [61]. The findings of Li’s 
study demonstrated that DNA damage in peripheral blood mononuclear cells was signifi-
cantly increased in a dose-dependent manner [62]. Abo-Elmagd et al. [63] showed the for-
mation of different types of structural chromosomal aberrations, where chromosomal and 
chromatid breaks had the dominant incidence. Moreover, damaging effect of radon in the 
blood and bone marrow was expressed as a reduction in the mitotic index and an increase in 
chromosome damage. The average frequencies of single and double fragments, chromosomal 
exchanges, total number of aberrations, chromatid type, chromosome type, and all types of 
aberrations were significantly increased in the radon-exposed group [64]. As reported by sev-
eral authors, there is a synergistic effect of smoking and radon on increasing the frequency of 
chromosomal aberrations. Meenakshi and Mohankumar showed that the frequency of dicen-
trics in radon-exposed smoker cells was found to be higher than non-smokers by factor of 
3.8 [65]. Moreover the comparison of three groups: miners, workers of uranium enterprises, 
and a control group revealed that chromosomal aberrations were a consequence of the effect 
of radon, but not of uranium [66]. Disruptions to normal chromosomal arrangement repre-
sent a major contribution to carcinogenesis. Cytogenetic analysis, including the detection of 
chromosomal aberrations, has been used for many decades as a tool to determine mutagenic 
and carcinogenic risks. Chromosomal aberrations (insertions, deletions, translocations, ring 
formation, duplication, and inversions) as a result of radon exposure significantly increase the 
risk of developing neoplastic processes and enhance carcinogenic ability and this can be one 
of the mechanisms of development of radon-induced lung cancer.
In addition to chromosomal aberrations, gene mutations play an important role in the 
pathogenesis of lung cancer. Specific “hotspot” mutations in cancer-relevant genes have 
been described in radon-induced lung cancer. Sequencing of the TP53 tumor-suppressor 
gene has provided links between specific mutations and radon exposure. TP53, also known 
as the “guardian of the genome” owing to its involvement in regulation of the cell cycle 
and apoptosis upon DNA damage, plays a critical role in the cellular response to genetic 
damage caused by radiation. Most papers on TP53 mutations in radon-associated lung 
cancer consist of occupational studies in uranium miners [67, 68]. These studies showed 
a TP53 mutational spectrum different from those seen in lung cancers caused by tobacco 
smoke. Vähäkangas et al. showed that most frequent base substitutions associated with 
tobacco smoking (G:C to T:A transversions) were not identified in uranium miners [67]. 
The study of Popp et al. indicated an overrepresentation of codon 213/3 polymorphism in 
p53 in radiation-caused cancers [69]. Some studies reported a radon-related TP53 hotspot 
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in codon 249, exon 7. These mutations, mostly transversions and small deletions very 
uncommon in smoke-induced lung cancers, were mainly identified in squamous cell car-
cinomas (SCC) and in large cell carcinomas. In the same cohort of miners, the presence of 
codon 249 transversion was not demonstrated in lung adenocarcinomas, thus implicating 
tumor histology as determinant for this specific mutation [70]. Only few studies analyzed 
TP53 punctual mutations in lung tumors from residential radon-exposed individuals and 
their results are not univocally supportive of the mentioned hotspot in codon 249 [71, 72]. 
However, Hollstein et al. proposed that loss of tumor-suppressor function of TP53 due to 
α-particle radiation may occur preferentially by mechanisms such as intrachromosomal 
deletions, rather than by base substitution mutations [73].
Accordingly, single nucleotide polymorphisms (SNPs) in TP53 sequence may affect lung 
cancer susceptibility by influencing hundreds of target genes. Nevertheless, the mechanistic 
details underlying the molecular pathways by which TP53 gene polymorphisms are associ-
ated with radon-induced lung cancer remain unclear.
Further investigations are required in order to understand if it is possible to identify hotspot 
regions for radon-induced lung cancers, providing a unique biomarker that contributes to under-
stand the etiology of the disease and to elucidate the risk as occurring at low exposure levels.
There is growing evidence that the tumor suppressive activity of TP53 is related with miRNA 
expression. miRNAs are small, non-coding RNAs regulating gene expression at the post-tran-
scriptional level. microRNAs bind to complementary sequences on target messenger RNA 
transcripts, usually resulting in translational repression or target mRNA degradation and 
gene silencing.
miRNA profiling after TP53 induction, pointed miR-34a/b/c as the most up-regulated miR-
NAs identifying miR-34 as a main TP53 gene effector [74]. The expression of miR-34 family 
members is induced after genotoxic stress in a p53-dependent manner in cultured cells as 
well as in irradiated mice [74–76]. Notably, overexpression of miR-34a increases apoptosis, 
whereas miR-34a inactivation strongly attenuates p53-mediated apoptosis in cells exposed to 
genotoxic stress. Further miRNAs, including miR-125a, have recently been linked to p53-reg-
ulated apoptosis in lung cancer cells [77]. Several TP53 mutants, linked to oncogenic pro-
gression, suppress post-transcriptional maturation of miRNAs bearing growth-suppressive 
functions [78].
As shown in a number of studies, the profile of microRNA can vary both under the action of 
chemical agents [79, 80] and radiation [81–86].
Recently, it has been shown that ionizing radiation can induce changes in miRNA expression 
profiles in normal human fibroblasts [87] and immortalized cell lines [88, 89]. In vivo studies 
found that miRNA signatures induced by ionizing radiations in mouse blood are dose and 
radiation type-specific [90] indicating that miRNAs can be exploited as biomarkers of expo-
sure to radiation [91].
Studies in humans also highlighted the importance of miRNAs to evaluate the biological 
outcomes of radiation exposure. Evidence from a study conducted in patients undergoing 
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radiotherapy, indicated that miRNA expression can be used as biomarker of radiation expo-
sure in humans [92]. Another study examined the utility of miRNA signatures in lung cancer 
screening using blood samples from computerized tomography trials. The authors performed 
extensive miRNA profiling of primary lung tumors, paired normal lung tissues, and multiple 
plasma samples collected before and at the time of the disease. This approach was able to 
define a plasma miRNA signature associated with increased risk of lung cancer [93]. Also 
other groups have integrated miRNA profiles into computerized tomography-screening pro-
grams [94, 95].
A number of studies have shown the radioprotective role of some types of microRNA. In vitro 
studies using the human diploid fibroblast cell line WI-38 demonstrated that the mature form 
of the miR-155 inhibits premature “cell aging” induced by radiation [96].
In this regard some scientists make a supposition that some microRNAs can determine the 
resistance of tumor cells to radiotherapy and be a prognostic biomarker for monitoring of 
cancer treatment strategy.
Ma et al. demonstrated that overexpression of miR-622 in colon cancer cells inhibits Rb by 
directly binding to RB1-3′UTR, thus inactivating the Rb-E2F1-P/CAF complex, which is 
responsible for the activation of pro-apoptotic genes in response to the effect of radiation [97].
On the other hand, many studies have shown that overexpression is one of the most common 
types of cancer. A study of 48 patients diagnosed with cervical cancer revealed the effect of 
miR-18a function in the regulation of cellular radiosensitivity. Liu et al. showed that miR-18a 
suppresses the activity of ATM, reduces the repair of double-strand breaks and stimulates 
apoptosis of irradiated cancer cells [98].
Similar results were obtained by Lan and colleagues in their study of non-small cell lung can-
cer. According to their results, miR-15 and miR-16 increase the radiosensitivity of H358 and 
A549 cell lines and the level of apoptosis in vitro [99].
Thus, the level of expression of different types of microRNA can react differently to the effect 
of ionizing radiation [100]. Most likely the effect of radiation depends on target genes inhib-
ited by a specific microRNA. However, according to numerous literature data, it is impossible 
to identify a clear separation of microRNAs with respect to radioactive effects. Expression of 
most of the currently known microRNAs can be amplified or suppressed by ionizing radia-
tion depending on the type of cells of their producing [100].
Other researchers believe that a change in the level of microRNA expression under the influ-
ence of radiation has a dose-dependent effect [101]. Lee et al. showed that the greatest effect 
on the profile of microRNAs in the mononuclear phagocytes of human blood exposed to 
different doses of radiation had 1 Gy irradiation, while 0.5 and 2.5 Gy irradiation showed 
very slight changes in the level of microRNA expression [101]. In order to explain the results 
obtained, the authors compared the biological effect in the cells and target genes of miRNAs 
sensitive to radiation. It turned out that the majority of these microRNAs were involved in the 
control of homeostasis, neuronal survival, and regulation of the cell cycle and proliferation. 
Thus, sensitive to radiation microRNA (including the action of small radiation doses) can be 
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involved in the pathogenesis of cancer caused by the action of radiation. Moreover, Japanese 
scientists from the University of Hiroshima, after conducting a study of patients diagnosed 
with stomach cancer exposed to large and small doses of radiation, found that the miR-24 
expression profile was largely changed in the first group. Based on the results obtained, Naito 
et al. suggest that miR-24 can be use as a biomarker risk of developing gastric cancer induced 
by radiation [102].
Despite the large number of works devoted to the study of the relationship between 
microRNA, radiation, and carcinogenesis, there are few studies about the role of microRNA 
in radon-induced lung cancer. Chen et al. reported that the level of expression of let-7 
microRNA in human bronchial epithelial (HBE) cells due to radon exposure is decreasing, 
which results in activation of the K-ras oncogene. Furthermore, a significant down-regu-
lation of K-ras was then confirmed in both let-7b-3p and let-7a-2-3p transfected HBE cells 
[103]. The results of this study proposed that let-7 microRNA and K-ras are involved in 
radon-induced lung damage both in vivo and in vitro. In vitro study of malignant trans-
formation due to radon exposure showed the change in the expression level of a number 
of microRNAs, including hsa-miR-483-3p, hsa-miR-494, hsa-miR-2115*, hsa-miR-33b, hsa-
miR-1246, hsa-miR-3202, hsa-miR-18a, hsa-miR-125b, hsa-miR-17*, and hsa-miR-886-3p. 
These miRNAs target genes play key role in the regulation of cell proliferation, differentia-
tion, adhesion during the process of malignant transformation, which are associated with 
different signal pathways such as mitogen-activated protein kinase (MAPK), Int and Wg 
(Wnt), reactive oxygen species (ROS), and nuclear factor κB (NF-κB) [104]. Recent study 
showed an increase in the expression of some circular RNA (class of endogenous non-pro-
tein coding RNAs that contain a circular loop) in mouse lung tissues due to radon exposure 
and 5 microRNAs binding sites detected for each circRNA. The authors suggest that these 
circRNAs and miRNAs could play important and synergistic roles in radon-induced lung 
damage, even in lung cancer [105].
Thus, the role of microRNA in the pathogenesis of radon-induced lung cancer is still unclear. 
Nevertheless, the search for biomarkers for early diagnosis of lung cancer, which can be use-
ful, especially for Kazakhstan, since most of the Republic’s territory has a high natural level 
of radon.
At the epigenetic level, not only miRNAs expression patterns, but specific alterations including 
alterations in DNA methylation, histone modifications leading to generation of γ-H2AX spe-
cies (indicative of double-strand DNA breaks) have been associated with radon exposure [106].
Masoomi et al. showed that people living in regions with a high natural background of radia-
tion had faster DNA repair [107]. Earlier, Fernandez-Capetillo et al. was proposed that H2AX 
phosphorylation may play an important role in the low-dose radiation adaptive response [108]. 
H2AX phosphorylation-induced chromatin restructuring for DNA repair/signaling factors 
and/or tether DNA ends. If this process is induced by low-dose radiation and if there is a mem-
ory for mounting this process in the event of a later enhanced genomic stress (e.g. high dose 
of carcinogen), more rapid and more efficient DNA repair might be expected to occur [109].
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DNA methylation is well-described in lung cancer and is considered to be potentially revers-
ible [110]. There is much less information about the effect of radon on the status of DNA 
methylation. In study of Chinese uranium workers has shown the methylation of O-6-
methylguanine-DNA methyltransferase (MGMT) and p16 gene in the sputum cells is related 
to the accumulate exposure dosage of the radon [111]. p16 is a tumor suppression gene, which 
plays key role in cell cycle regulation and methylation p16 gene is significantly associated 
with non-small cell lung cancer (NSCLC) [112]. O-6-methylguanine-DNA methyltransfer-
ase is a DNA repair enzyme which protected cells from the carcinogenic effect of alkylat-
ing agents. The hypermethylation of the MGMT gene’s promoter may play a significant role 
in lung carcinogenesis [113]. Belinsky et al. has shown that exposure to plutonium, which 
similar to radon exerts its effects through alpha particles, can induce p16 gene inactivation by 
promoter methylation [114].
It is known, that radon is the first reason of lung cancer in never smoking population. But 
some studies showed that higher methylation rate in p16 is dependent on the amount of expo-
sure to tobacco smoke and this epigenetic change is specific to smokers with lung cancer [115]. 
By comparison in non-smokers patients with lung cancer, the methylation rate in p16 is low 
[116]. Bastide et al. concluded that, in radon-induced rat lung tumors, promoter methylation 
did not affect the p16 gene inactivation although the lack of p16 protein expression in lung 
tumors remains to be established [117].
The study in United States showed exposure to radon through uranium mining did not affect 
the prevalence for MGMT methylation [118].
Perhaps, in this case we are talking about the dose-dependent effect of radon on epigenetic 
reprogramming. High-dose radiation can promote epigenetically silencing of adaptive-response 
genes, while low doses of natural radiation can, on the contrary, have a protective effect and 
activate the same genes through changes at the epigenetic level. More importantly, according 
to the Environmental Protection Agency low-level radon exposure (4 pCi L − 1) may actually 
be protective against lung cancer [119]. Some study demonstrated cancer prevention after low-
level radiation exposure [120, 121]. For this reason it will require more research to reconcile 
these contradictory data.
There is not much information about the effect of radon exposure on histone modification. The 
study by Pogribny has shown the effect of low-dose radiation exposure on histone H4-Lys 
20 trimethylation in the thymus tissue using an in vivo murine model. In such a case, the 
loss of histone H4-Lys20 trimethylation was accompanied by a significant increase in global 
DNA hypomethylation and reduced expression of DNMT1 and DNMT3b. Moreover, the lev-
els of methyl-binding proteins MeCP2 and MBD2 were significantly reduced in thymus of 
exposed females and males mice compared with respective controls. In such a case, the loss 
of histone H4-Lys20 trimethylation was accompanied by a significant increase in global DNA 
hypomethylation and reduced expression of DNMT1 and DNMT3b. Moreover, the levels of 
methyl-binding proteins MeCP2 and MBD2 were significant decreased in thymus of exposed 
females and males mice compared with respective controls [122].
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The studies of specific molecular mechanisms that can lead to genetic and epigenetic aber-
rations in lung tumor genomes as a result of exposure to radon can give a unique opportu-
nity for further developing diagnostic and identification of candidates for therapeutic targets. 
However future studies are needed to explore both the genetic and epigenetic mechanisms in 
pathogenesis of cancer and fully elucidate the effects of radon on health and disease.
11. Lung cancer studies in Kazakhstan
According to the latest WHO data published in May 2014, lung cancers deaths in Kazakhstan 
reached 3836 or 2.58% of total deaths. The age adjusted death rate is 26.24 per 100,000 of popu-
lation ranks Kazakhstan #36 in the world [123]. Currently, Kazakhstan is in need of advanced 
actions to reduce lung cancer rate. However, unfortunately, in Kazakhstan there are very few 
studies of the genetic and epigenetic mechanisms of the lung cancer pathogenesis, especially 
the radon-induced action.
Sagyndykova studied the cellular and molecular carcinogenic effects on lung tissue due to 
radiation exposure on the population, lived on the territories of Semipalatinsk region. These 
territories were used for testing nuclear weapons for the Soviet army during the period 
1949–1989. The results of the study showed a higher level of expression of IGFBP1, IGFBP2, 
p53, c-mus, bax and reduced expression of IGFBP3, IGFBP4, IGFBP5, bcl-2 in tumor cells 
compared to the control group (patients with lung cancer not due to radiation). Probably 
there are some differences in the mechanisms of proliferation, differentiation, and apoptosis 
in radiation-induced lung tumors [124]. We have long been studying the effect of radiation 
in the population of Kazakhstan [125]. In our previously study, we showed the association 
between the Gln/Gln genotype of gene XRCC1 and the frequency of chromosomal aberrations 
in the uranium workers. The frequency of chromosomal aberrations in heterozygous carri-
ers of the XRCC3gene Thr/Met was lower than in the homozygous carriers of the wild type 
Thr/Thr [126]. It is known that DNA repair genes are involved in the formation of individual 
sensitivity to radiation exposure. Larionov et al. showed that three SNP of DNA repair genes 
may be considered as radon-sensitive markers [127]. Considering the fact, that the associa-
tion between the DNA repair genes polymorphisms and radon exposure was found, similar 
studies indicate a prospect of searching for markers of individual sensitivity to radon among 
allelic variants of key DNA repair genes.
As discussed previously in the review, in addition to genetic factors, the epigenetic changes 
play an important role in the pathogenesis of lung cancer, including radon-induced lung cancer. 
One of the goals of contemporary cancer research is the development of new markers that 
facilitate earlier and non-invasive diagnosis. Studies have shown that miRNAs expression 
levels are altered in cancer. Recently, extra-cellular miRNAs have been detected in biologi-
cal fluids and studied as possible cancer markers that can be detected by non-invasive pro-
cedures. The serum concentrations of several microRNAs have been associated with lung 
cancer [128]. Moreover, miRNAs have been reported to play an important role in inducing 
resistance to anti-cancer drugs [129]. miRNAs can be exploited not only as biomarkers of 
radiation exposure but also as biomarkers of lung cancer. The problem of the health risk 
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exposed to radon is not sufficiently studied on the populations of Kazakhstan, although the 
country (mainly its East and North areas) has the regions containing the high levels of radon 
[10]. Currently, we aim at addressing the role of genetic and epigenetic factors affecting sus-
ceptibility to radon exposure. At epigenetic level, we investigate the effects of radon on the 
expression of miRNAs in the blood plasma of exposed subjects. This will allow us to validate 
circulating miRNAs as a reliable biomarker of early biological effect to be used prior to the 
development of lung cancer in a high-risk population. Particularly, it is very promising to 
develop highly specific and efficient test systems of lung cancer based on molecular markers, 
which levels the change due to radon exposure.
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